Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer.
Di Lorenzo G, Pizza C, Autorino R, De Laurentiis M, Marano O, D'Alessio A, Cancello G, Altieri V, Tortora G, Perdonà S, Bianco AR, De Placido S.
Di Lorenzo G, et al. Among authors: de placido s, de laurentiis m.
Eur Urol. 2004 Dec;46(6):712-6. doi: 10.1016/j.eururo.2004.08.022.
Eur Urol. 2004.
PMID: 15548437
Clinical Trial.